SCHEMBL3850936

SCHEMBL3850936

O=C(Nc1cc(Br)ccc1F)c1ccccc1C(=O)c1ccc2n[c][nH]c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 4/20 0.43
▸ MAPT P10636 5/20 0.42
▸ NR1H4 Q96RI1 2/20 0.41
▸ PPARG P37231 1/20 0.41
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ TYK2 P29597 1/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3855951 0.88 NPSR1 (0.48) MAPTNR1H4PPARGCYP2C9CYP2C19
SCHEMBL4470605 0.88 NPC1 (0.40) GPR35MAPTNR1H4PPARGCYP2C9
SCHEMBL27774235 0.86 PPARG (0.39) MAPTNR1H4PPARGCYP2C9CYP2C19
SCHEMBL3848177 0.84 MAPT (0.44) MAPTNR1H4PPARGCYP2C9CYP2C19
SCHEMBL4473204 0.80 NPC1 (0.41) MAPTNR1H4PPARGCYP2C9CYP2C19
SCHEMBL4464511 0.80 MAPT (0.44) MAPTNR1H4PPARGCYP2C9CYP2C19
SCHEMBL2297867 0.80 RAF1 (0.54) MAPTCYP2C9CYP2C19KMT2ATP53
SCHEMBL3857514 0.79 RAF1 (0.38) MAPTNR1H4PPARGCYP2C9CYP2C19
SCHEMBL4469804 0.79 HTT (0.46) MAPTCYP2C9CYP2C19KMT2ANPC1
SCHEMBL3848804 0.78 NPSR1 (0.48) MAPTNR1H4PPARGKMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-A1 METHODS OF USING MEK INHIBITORS Exelixis, Inc. (US) 2009-09-23 — — EP claimed
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 — — WO claimed
WO-2008076415-A1 METHODS OF USING MEK INHIBITORS EXELIXIS, INC. (US) 2008-06-26 — — WO claimed
Send feedback